Muscle relaxants may boost oxygen in severe COVID-19 lung failure
NCT ID NCT04922814
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether giving muscle relaxants along with sedation helps improve oxygen levels in patients with severe COVID-19 lung failure (ARDS) who need a breathing machine. Forty adults were enrolled. The goal was to see if this approach could reduce complications and improve survival in the ICU.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 ACUTE RESPIRATORY DISTRESS SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Assiut university, faculty of medicine, anesthesia and ICU and pain management department
Asyut, Asyut Governorate, 71515, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a gentle oxygen boost make lung biopsies safer and faster?
- Could a simple patch replace painful needle tests for ICU muscle weakness?
- Why COVID-19 lungs fail: tiny blood vessel damage may be key
- Could a softer sedation and early exercise keep ICU patients stronger?
- Could a common anesthetic gas help ICU patients breathe better on ventilators?
- Ultrasound breakthrough could predict ICU paralysis days in advance